This blog is for people who have information about corporate bribery and would like information about the Dodd-Frank reward program.
Whistleblowers who are working for SEC-regulated companies outside of the U.S. should report their companies’ violations of the U.S. Foreign Corrupt Practices Act (FCPA) directly to the U.S. Securities and Exchange Commission (SEC) and forgo reporting internally to...read more
Whistleblowers are eligible for rewards for reporting pharmaceutical and medical device companies bribing foreign officials. This includes paying and providing benefits, including trips, entertainment, and job opportunities, to officials at the Ministry of Health...read more
This is part IV of my international reward whistleblower series where I address frequently asked questions posed by people who are interested in filing a reward submission to the SEC. Part IV will focus on questions relating to whether certain corporate employees and...read more
FCPA whistleblowers who report companies bribing foreign immigration officials to the SEC may be eligible for a reward under the Dodd-Frank program. SEC-regulated companies and their subsidiaries and affiliates will sometimes bribe foreign immigration officials to...read more
SEC whistleblowers who report companies bribing foreign tax and revenue officials may be eligible for a reward under the Dodd-Frank program. SEC-regulated companies and their subsidiaries and affiliates will sometimes bribe foreign tax and revenue officials to obtain...read more
Corporate whistleblowing is booming in Russia. The U.S. Securities and Exchange and Commission’s 2017 whistleblower report shows a 333% increase of whistleblowers coming from Russia. The SEC’s 2016 whistleblower report showed that six people from Russia had made...read more
This is part V of my FCPA Rewards Pharma Series. Part I of the series can be viewed here, part II can be viewed here, part III can be viewed here, and part IV can be viewed here. This video focuses on how pharma bribes doctors and officials by giving them trips,...read more
People who report healthcare companies bribing government doctors or officials may be eligible for a reward under the Dodd-Frank program. Pharma has been bribing doctors by sponsoring and donating to their medical associations and foundations. A key opinion leader or...read more
China offers many opportunities for whistleblowers who want to obtain a reward for reporting violations of the Foreign Corrupt Practices Act (FCPA) to the Securities and Exchange Commission (SEC). Much of China’s economy is controlled and operated by either the...read more
This is part IV of my FCPA Rewards Pharma Series. Part I of the series can be viewed here, part II of the series can be viewed here, and part III can be viewed here. This video focuses on the pharmaceutical and healthcare sector bribing doctors by hiring and engaging...read more
Andy Rickman is an SEC whistleblower attorney who has filed Dodd-Frank FCPA reward submissions for international clients residing in more than 50 different countries. He is based in Washington, DC where Dodd-Frank reward submissions are filed and the SEC is headquartered.
For anyone who wants more information on the Dodd-Frank reward program, please email him at firstname.lastname@example.org or visit his law firm’s website at www.rickmanlegal.com. Mr. Rickman offers a free consultation to anyone who would like to discuss whether he or she has a Dodd-Frank reward eligible case.